Bank of Montreal
SGNT

Bank of Montreal’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bank of Montreal’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-36,720
Closed -$551K – 4351
2016
Q2 		$551K Buy
36,720
+774
+2% +$9.94K ﹤0.01% 2083
2016
Q1 		$437K Buy
35,946
+5,783
+19% +$81.1K ﹤0.01% 2102
2015
Q4 		$480K Buy
30,163
+5,347
+22% +$84.2K ﹤0.01% 2008
2015
Q3 		$380K Sell
24,816
-6,013
-20% -$130K ﹤0.01% 1983
2015
Q2 		$750K Buy
30,829
+6,950
+29% +$166K ﹤0.01% 1790
2015
Q1 		$556K Buy
23,879
+9,514
+66% +$252K ﹤0.01% 1879
2014
Q4 		$361K Buy
14,365
+1,809
+14% +$53.1K ﹤0.01% 2220
2014
Q3 		$390K Sell
12,556
-162
-1% -$4.39K ﹤0.01% 2197
2014
Q2 		$328K Buy
12,718
+545
+4% +$12.1K ﹤0.01% 2298
2014
Q1 		$285K Buy
12,173
+1,490
+14% +$32.6K ﹤0.01% 2354
2013
Q4 		$271K Buy
10,683
+1,186
+12% +$26.8K ﹤0.01% 2106
2013
Q3 		$194K Buy
+9,497
New +$211K ﹤0.01% 2256

Bank of Montreal's SGNT Position: Q3 2016 in Review

Bank of Montreal sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 36,720 shares — an estimated $551K sold.

Bank of Montreal first reported a position in SGNT in Q3 2013 and held it in 12 quarters. The position peaked at $750K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Bank of Montreal reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Bank of Montreal sold 36,720 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $551K.
  • Bank of Montreal first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 12 quarters.
  • Bank of Montreal's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $750K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Bank of Montreal's 13F filing for Q3 2016, filed 19 Oct 2016.